ABBV · News · 20260805N

Outstanding Indebtedness

AbbVie Inc. · 2026-08-05 · Importance 64 · Surprise 42

AbbVie launched a $10 billion bond sale to finance its pending Apogee Therapeutics acquisition. Earlier reporting indicated the company was seeking to raise at least $8 billion in debt for the transaction. The debt financing will increase leverage to fund the approximately $10.9 billion acquisition.

Key facts

• AbbVie plans to raise $8 billion through investment-grade bonds to fund its $10.9 billion acquisition of Apogee Therapeutics Inc. source